Table 5 Proportion of articles found for each perspective considered and assigned interest (%)
From: Patient reported outcomes in oncology: changing perspectives—a systematic review
HRQoL | Systematic reviews | Research | Retrospective and protective | High interest | Moderate interest | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yes | No | Yes | No | Yes | No | Yes | No | Yes | No | Yes | No | |
Oncology perspectives | ||||||||||||
Oncology patients | ||||||||||||
Stepped care models | 32.4 | 37.7 | 27.6 | 48.0 | 42.2 | 5.3 | 32.6 | 35.0 | 18.2 | 39.3 | 38.7 | 19.0 |
Prognosis value | 26.5 | 51.0 | 41.4 | 40.0 | 45.3 | 26.3 | 34.9 | 47.5 | 27.3 | 49.5 | 45.5 | 28.6 |
Communication | 44.1 | 44.9 | 46.6 | 40.0 | 51.6 | 21.1 | 34.9 | 55.0 | 22.7 | 52.5 | 51.6 | 28.8 |
Patient safety | 52.9 | 44.9 | 53.4 | 36.0 | 51.6 | 36.8 | 39.5 | 57.5 | 27.3 | 55.7 | 54.8 | 28.6 |
Risk identification | 50.0 | 67.3 | 63.8 | 52.0 | 65.6 | 42.1 | 51.2 | 70.0 | 50.0 | 63.9 | 62.9 | 52.4 |
Caregivers | ||||||||||||
Communication improvements | 8.8 | 8.2 | 10.3 | 4.0 | 6.3 | 15.8 | 7.0 | 10.0 | 9.1 | 8.2 | 8.1 | 9.5 |
Supportive care guidance | 11.8 | 6.1 | 10.3 | 4.0 | 7.8 | 10.5 | 4.7 | 12.5 | 9.1 | 8.2 | 8.1 | 9.5 |
Caregiver support and unmet needs identification | 17.6 | 16.3 | 24.1 | 0.0 | 7.8 | 47.7 | 16.3 | 17.5 | 27.3 | 13.1 | 14.5 | 23.8 |
Caregiver burden | 17.6 | 20.4 | 24.1 | 8.0 | 14.1 | 36.8 | 18.6 | 20.0 | 27.3 | 16.4 | 16.1 | 28.6 |
Health systems | ||||||||||||
Futures perspectives in oncology | 50.0 | 46.9 | 51.7 | 40.0 | 43.8 | 63.2 | 46.5 | 50.0 | 27.3 | 55.7 | 56.5 | 23.8 |
Economical decisions, cost-effective measures | 8.8 | 2.0 | 3.4 | 8.0 | 6.3 | 0.0 | 4.7 | 5.0 | 4.5 | 4.9 | 4.8 | 4.8 |
Drug approval | 5.9 | 4.1 | 1.7 | 12.0 | 6.3 | 0.0 | 7.0 | 2.5 | 0.0 | 6.6 | 6.5 | 0.0 |
Patient centered care | 64.7 | 59.2 | 63.8 | 56.0 | 65.6 | 47.4 | 51.2 | 72.5 | 50.0 | 65.6 | 64.5 | 52.4 |
Implementation perspectives | ||||||||||||
Oncology patients | ||||||||||||
Staff involvement | 20.6 | 20.4 | 24.1 | 12.0 | 21.9 | 15.8 | 14.0 | 27.5 | 0.0 | 27.9 | 27.4 | 0.0 |
Institution approval | 14.7 | 12.2 | 19.0 | 0.0 | 15.6 | 5.3 | 2.3 | 25.0 | 0.0 | 18.0 | 17.7 | 0.0 |
Clear workflows | 20.6 | 22.4 | 31.0 | 0.0 | 23.4 | 15.8 | 9.3 | 35.0 | 0.0 | 29.5 | 29.0 | 0.0 |
Team continuous formation | 14.7 | 14.3 | 20.7 | 0.0 | 15.6 | 10.5 | 4.7 | 25.0 | 0.0 | 19.7 | 19.4 | 0.0 |
Data analysis | 17.6 | 20.4 | 25.9 | 4.0 | 21.9 | 10.5 | 7.0 | 32.5 | 0.0 | 26.2 | 25.8 | 0.0 |
Oncology patients | ||||||||||||
Research intervention | 8.8 | 18.4 | 20.7 | 0.0 | 15.6 | 10.5 | 4.7 | 25.0 | 0.0 | 19.7 | 19.4 | 0.0 |
Clinical interventions | 29.4 | 20.4 | 29.3 | 12.0 | 26.6 | 16.8 | 14.0 | 35.0 | 9.1 | 29.5 | 29.0 | 9.5 |
Medical interventions | 14.7 | 16.3 | 22.4 | 0.0 | 17.2 | 10.5 | 4.7 | 27.5 | 0.0 | 21.3 | 21.0 | 0.0 |
Physiological interventions | 5.9 | 12.2 | 13.8 | 0.0 | 10.9 | 5.3 | 2.3 | 17.5 | 4.5 | 11.5 | 11.3 | 4.8 |
Social interventions | 0.0 | 4.1 | 3.4 | 0.0 | 1.6 | 5.3 | 2.3 | 2.5 | 0.0 | 3.3 | 3.2 | 0.0 |
Oncology patients | ||||||||||||
Use for clinical purposes | 55.9 | 55.1 | 56.9 | 52.0 | 57.8 | 47.4 | 48.8 | 62.5 | 27.3 | 65.6 | 66.1 | 23.8 |
Use for research purposes | 20.6 | 24.5 | 27.6 | 12.0 | 23.4 | 21.1 | 16.3 | 30.0 | 4.5 | 29.5 | 29.0 | 4.8 |
Use for economical purposes | 8.8 | 10.2 | 6.9 | 16.0 | 10.9 | 5.3 | 11.6 | 7.5 | 0.0 | 13.1 | 12.9 | 0.0 |
Quality of care | 58.8 | 57.1 | 70.7 | 28.0 | 54.7 | 68.4 | 41.9 | 75.0 | 59.1 | 57.4 | 58.1 | 57.1 |